Health benefits of walnut polyphenols: An exploration beyond their lipid profile. by Sánchez González, Claudia Alejandra et al.
Full Terms & Conditions of access and use can be found at
http://www.tandfonline.com/action/journalInformation?journalCode=bfsn20
Download by: [UNIVERSITAT DE BARCELONA] Date: 18 January 2016, At: 10:14
Critical Reviews in Food Science and Nutrition
ISSN: 1040-8398 (Print) 1549-7852 (Online) Journal homepage: http://www.tandfonline.com/loi/bfsn20
Health benefits of walnut polyphenols: An
exploration beyond their lipid profile
Claudia Sánchez-González, Carlos Ciudad, Véronique Noé & Maria Izquierdo-
Pulido
To cite this article: Claudia Sánchez-González, Carlos Ciudad, Véronique Noé &
Maria Izquierdo-Pulido (2015): Health benefits of walnut polyphenols: An exploration
beyond their lipid profile, Critical Reviews in Food Science and Nutrition, DOI:
10.1080/10408398.2015.1126218
To link to this article:  http://dx.doi.org/10.1080/10408398.2015.1126218
Accepted author version posted online: 29
Dec 2015.
Submit your article to this journal 
Article views: 61
View related articles 
View Crossmark data
ACCEPTED MANUSCRIPT 
ACCEPTED MANUSCRIPT 1 
Health benefits of walnut polyphenols: An exploration beyond their lipid profile 
 
Claudia Sánchez-González
1
 Carlos Ciudad
2
, Véronique Noé
2
, & Maria Izquierdo-Pulido
1,3*a
 
1
 Departament of Food Science and Nutrition, Facultad de Farmacia y Ciencias de los Alimentos, 
Universidad de Barcelona, Av. Joan XXIII s/n, 08028 Barcelona, Spain; 
2
 Department of 
Biochemistry and Molecular Biology, Universidad de Barcelona, Barcelona, Spain; 
3
CIBER 
Physiopathology of Obesity and Nutrition (CIBEROBN), Instituto de Salud Carlos III, Madrid, 
Spain. 
* Corresponding author: Dr Maria Izquierdo-Pulido: maria_izquierdo@ub.edu  
 
ABSTRACT 
Walnuts are commonly found in our diet and have been recognized for their nutritious properties 
for a long time. Traditionally, walnuts have been known for their lipid profile which has been 
linked to a wide array of biological properties and health-promoting effects. In addition to 
essential fatty acids, walnuts contain a variety of other bioactive compounds such as, vitamin E 
and polyphenols. Among common foods and beverages, walnuts represent one of the most 
important sources of polyphenols, hence, their effect over human health warrants attention. The 
main polyphenol in walnuts is pedunculagin, an ellagitannin. After consumption, ellagitannins 
are hydrolyzed to release ellagic acid, which is converted by gut microflora to urolithin A and 
other derivatives, such as urolithins B, C and D. Ellagitannins possess well known antioxidant 
and anti-inflammatory bioactivity and several studies have assessed the potential role of ETs 
against disease initiation and progression, including cancer, cardiovascular and 
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neurodegenerative diseases. The purpose of this review is to summarize current available 
information relating to the potential effect of walnut polyphenols in health maintenance and 
disease prevention.  
 
Keywords: Walnuts, Polyphenols, Ellagitannins, Disease Prevention, Health 
 
1. INTRODUCTION 
Walnuts (Juglans regia L.) have been long consumed as a highly nutritious food in many 
parts of the world and they are an important component of the Mediterranean diet (Bulló, 
Lamuela-Raventós, & Salas-Salvadó, 2011).  Recently, they have been gathering attention for 
their health-promoting properties, which have been reported to improve lifestyle-related diseases. 
The health benefits of walnuts are attributed to several of their nutrients, such as, ω-3 fatty acids 
(Ros et al., 2004), vitamin E (Maguire, O'Sullivan, Galvin, O'Connor, & O'Brien, 2004), and 
dietary fiber. In addition to these nutrients, walnuts are rich in plant sterols and especially in 
polyphenols, as it has been reported recently (Vinson and Cai, 2012; Regueiro et al., 2014). The 
implications of polyphenols in human health are numerous and include beneficial effects over 
several disease states including: cardiovascular system dysfunction and damage (Estruch et al., 
2013), metabolic syndrome (Murase et al., 2011), diabetes (Li et al., 2011), various 
inflammation-related pathologies (Konstantinidou et al., 2010), and cancer (Thangapazham et 
al., 2007; Nkondjock, 2009). In addition, polyphenols have been recently described as 
potentially beneficial compounds for neuroprotection, (Granzotto and Zatta, 2014) and against  
aging (Granzotto and Zatta, 2014; Peng et al., 2014)
 
.
  
 Ellagitannins, polyphenols typically found 
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in walnuts, and their derived metabolites possess a wide range of biological activities which 
suggest that they could have beneficial effects on human health (Espín et al., 2013). The purpose 
of this review is to summarize the available information about the health-promoting effects of 
walnut polyphenols, mainly pedunculagin and its metabolites, ellagic acid and urolithins.  
 
2. CHEMISTRY AND METABOLISM OF WALNUT POLYPHENOLS  
Vinson & Cai (2012) reported that walnuts represent the seventh largest source of total 
polyphenols among common foods and beverages based on their serving size. A handful of 
walnuts, about 50g, has significantly more total polyphenols than a glass of apple juice (240 
mL), a milk chocolate bar (43g) or a glass of red-wine (150mL) which are all common food 
sources of polyphenols (Anderson et al., 2001). Moreover, walnut’s total polyphenols were 
significantly higher compared to other nuts such as almonds, hazelnuts, pistachios, and peanuts 
(Abe, Lajolo, & Genovese, 2012; Vinson & Cai, 2012). Indeed, the total polyphenol content 
reported range from 1,576mg to 2,499mg per 100g of walnuts (Vinson and Cai, 2012). In 
addition, walnut polyphenol extracts also exhibited high antioxidant potential, with an 
antioxidant capacity of 21.4 ± 2.0mmol TE/100g and 25.7 ± 2.1mmol TE/10g measured by 
ABTS+ and DPPH assays, respectively (Regueiro et al., 2014) .  
It is well documented that the most abundant polyphenols in walnuts are ellagitannins, 
mainly pedunculagin  (Figure 1) (Cerdá et al., 2005; Regueiro et al., 2014). Ellagitannins 
exhibit structural diversity according to food source. Although regardless of food source, 
ellagitannins are characterized by one or more hexahydroxydiphenoyl moieties esterified to a 
polyol (Regueiro et al., 2014). Previous studies of rat intestinal contents showed that 
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ellagitannins could be hydrolyzed to ellagic acid at the pH found in the small intestine and cecum 
(Daniel et al., 1989; Garcia-Muñoz and Vaillant, 2014). The presence of free ellagic acid in 
human plasma could be due to its release from the hydrolysis of ellagitannins, enabled by 
physiological pH and/or gut microbiota.  Ellagic acid is further metabolized by gut flora to form 
urolithins, mainly urolithin A and B (Landete, 2011), which are probably synthesized in the 
colon (Garcia-Muñoz and Vaillant, 2014) (Figure 1).  These urolithins circulate in blood and can 
reach many of the target organs where the effects of ellagitannins are observed (Larrosa, Tomás-
Barberán, et al., 2006). The occurrence of ellagitannins and ellagic acid in the bloodstream is 
almost negligible, but their derived metabolites, urolithins, can reach a concentration at 
micromolar levels in plasma (Larrosa, González-Sarrías, et al., 2006).  It is important to note that 
urolithin concentration  in plasma and urine after ingestion of  ellagitannin-rich foods can differ 
between individuals due to individual differences in gut microbiota (Garcia-Muñoz and Vaillant, 
2014). In addition to urolithin concentration, specific urolithin production can vary between 
individuals. A recent study identified three urolithin-producing phenotypes,  related to the 
type of urolithins produced after consumption of ellagitannin food sources (Tomás-Barberán et 
al., 2014).  
 
3. BIOLOGICAL EFFECTS OF WALNUT POLYPHENOLS AND THEIR DERIVED 
METABOLITES 
Effects on oxidative stress 
Oxidative stress can be defined as an imbalance between free radical and reactive 
metabolites, such as reactive oxygen species (ROS), production and their elimination.  This lack 
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of balance can lead to cell damage potentially creating an impact in an organism as a whole 
(Ďuračková, 2010).  Inflammation can be caused as a consequence of oxidative stress, and 
although excess in ROS is not the only cause, inflammation resulting from oxidative stress is the 
origin of many diseases (Martinon, 2010). Typical examples are dyslipidemia (Hopps et al., 
2010), thrombosis (Leopold and Loscalzo, 2009), metabolic syndrome (Hopps et al., 2010), type 
2 diabetes (Kaneto et al., 2010),  nonalcoholic steatohepatitis (NASH) (Hijona et al., 2010), 
macular degeneration (Augustin and Kirchhof, 2009), neurodegenerative diseases such as 
Alzheimer’s  (Candore et al., 2010) and cancer (Hussain et al., 2003). During inflammation, 
mast cells and leukocytes are recruited to the site of damage, which leads to a “respiratory burst” 
due to an increased uptake of oxygen, and thus, an increased release and accumulation of ROS 
(Hussain et al., 2003). On the other hand, inflammatory cells also produce soluble mediators, 
such as metabolites of arachidonic acid, cytokines and chemokines, which act by further 
recruiting inflammatory cells to the site of damage and producing more reactive species. Over 
the years, epidemiologic and observational evidence has encouraged belief in the use of bioactive 
compounds with antioxidant potential for disease prevention (Stanner et al., 2007). Considering 
the previously mentioned antioxidant capacity of ellagitannins it is interesting to explore the 
potential of these compounds in disease prevention.  
UV radiation from the sun is a potent environmental risk factor in the pathogenesis of 
skin damage, much of the damage caused by UVA irradiation is associated with oxidative stress. 
Ellagic acid may be useful for the treatment of ultra-violet induced skin damage. In an in vitro 
study, Hseu et al (2012) showed that an ellagic acid pre-treatment markedly increased HaCaT 
human keratocyte cell viability and suppressed UVA-induced ROS generation and 
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malondialdehyde (MDA) formation (Hseu et al., 2012). Moreover, ellagic acid pre-treatment 
prevented UVA-induced DNA damage and significantly inhibited the UVA-induced apoptosis of 
HaCaT cells. The antioxidant potential of ellagic acid was directly correlated with the increased 
expression of  heme oxygenase 1 (HO-1) and superoxide dismutase (SOD), which was followed 
by the down regulation of kelch-like ECH-associated protein 1 (Keap1) and the augmented 
nuclear translocation and transcriptional activation of nuclear factor (erythroid-derived 2)-like 2 
(Nrf2) with or without UVA irradiation (Hseu et al., 2012). These results support the role of 
ellagic acid in activating a response against oxidative stress (Figure 2).  
Ellagic acid has also shown a protective role against nicotine-induced toxicity in rat 
peripheral blood lymphocytes (Sudheer et al., 2007). Lymphocytes incubated with nicotine 
showed a significant increase in the levels of lipid peroxidation index, severity in DNA damage 
and micronuclei number. Those effects were modulated by ellagic acid treatment. Antioxidant 
status was also significantly depleted in nicotine-treated group, which was effectively restored by 
ellagic acid incubation (Sudheer et al., 2007). 
Anti-inflammatory effects 
The protective role of ellagitannins and its metabolites against acute inflammation has 
been explored in in vivo and in vitro models (Umesalma and Sudhandiran, 2010; Ahad et al., 
2014; El-Shitany et al., 2014) (Figure 3). Ellagic acid exhibited a potent anti-inflammatory effect 
against carrageenan-induced inflammation (El-Shitany et al., 2014). The mechanisms by which 
ellagic acid protected against inflammation could be linked to the reduction of inflammatory 
molecules such as, nitric oxide (NO), malondialdehyde (MDA), interleukin-1 beta (IL-1β), tumor 
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necrosis factor alpha (TNF-α), cyclooxygenase 2  (COX-2) and nuclear factor-κB (NF-κB) 
expression, and the induction of glutathione (GSH) and IL-10 production (El-Shitany et al., 
2014). Urolithins have also been linked to cause a protective effect in acute inflammation. 
Ishimoto and colleagues investigated the anti-inflammatory role of urolithin A in carrageenan-
induced paw edema in mice (Ishimoto et al., 2011). The volume of paw edema was reduced 1 h 
after oral administration of urolithin A. In addition, plasma exhibited significant oxygen radical 
antioxidant capacity (ORAC) scores in treated mice, correlating with high plasma levels of the 
unconjugated form 1 h after oral administration of urolithin A (Ishimoto et al., 2011). These 
studies show that both ellagic acid and its bioactive metabolite urolithin A exert anti-
inflammatory effects by several mechanisms, including the reduction of oxidation and 
inflammatory cytokines.  
Of particular interest is the role of ellagic acid and their metabolites on colon 
inflammation, which can help elucidate the potential role of ellagitannin-containing foods, such 
as walnuts, on preventing gut inflammatory diseases. Colon fibroblasts CCD18-Co cells were 
exposed to a mixture of urolithins A and B and ellagic acid, at concentrations comparable to 
those found in the colon (Giménez-Bastida et al., 2012). The effects on fibroblast migration and 
monocyte adhesion were also determined. The mixture of polyphenol metabolites significantly 
inhibited colon fibroblast migration by about 70% and monocyte adhesion to fibroblasts by about 
50%. These effects were parallel with a significant down-regulation of inflammatory markers 
such as prostaglandin E2  (PGE2), plasminogen activator inhibitor 1 (PAI-1), and IL-1β, as well 
as other key regulators of cell migration and adhesion (Giménez-Bastida et al., 2012). The 
results show that a combination of the ellagitannin metabolites at concentrations achievable in 
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the intestine after the consumption of ellagitannin-containing foods, such as pomegranate or 
walnuts, was able to moderately improve the inflammatory response of colon fibroblasts and 
suggest that consumption of ellagitannin-containing foods has potential beneficial effects on gut 
inflammatory diseases. Additionally, a recent study further confirms the protective effect 
urolithins have over intestinal inflammation using RAW 264.7 murine macrophages as a model 
(Piwowarski et al., 2015).  Urolithins A, B and C decreased NO production via inhibition of the 
iNOS protein, and expression of IL-1β, TNF-α and IL-6 (Piwowarski et al., 2015). 
 Inflammatory processes are associated to several pathological conditions. Available data 
indicate that the development of diabetic nephropathy, a serious complication confronted by 
diabetic patients, is also linked to inflammation. A study performed in type 2 diabetic Wistar 
albino rats evaluated the nephro-protective effects of ellagic acid (Ahad et al., 2014). Ellagic 
acid treatment for 16 weeks after induction of diabetes significantly attenuated renal dysfunction 
and oxidative stress. It also significantly inhibited renal NF-kB activation, lowered renal 
pathology, suppressed transforming growth factor-beta (TGF-β) and fibronectin expressions in 
renal tissues.  Moreover, ellagic acid significantly reduced the serum levels of pro-inflammatory 
cytokines, IL-1β, IL-6 and TNF-α (Ahad et al., 2014) . Thus, these authors concluded that ellagic 
acid exerted a renal protective effect in type 2 diabetic rats by a multifactorial approach through 
anti-hyperglycemic, anti-glycative, antioxidant and anti-inflammatory effects. Taking this 
evidence into account, the anti-inflammatory properties of ellagitannins potentially exert a 
protective effect against a wide range of pathologies and their complications.  
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Estrogenic and androgenic interactions 
There has been increased interest in studying the activity of phytoestrogens due to their 
potential health benefit. The modulation of hormone receptors by phenolic dietary components 
has been widely studied, many polyphenols, including isoflavones, flavanones and stilbenes have 
shown phytoestrogenic activity (Mantena et al., 2006; Thangapazham et al., 2007; Tu et al., 
2011; Wang et al., 2011). Dietary polyphenols may also be precursors of bioactive compounds 
with estrogenic activity and ellagitannins, particularly their metabolites urolithins A and B, can 
be included in this group (Figure 4). A study has assessed the potential activity of urolithins as 
hormone-disruptive molecules, exerting both estrogenic and anti-estrogenic activity (Larrosa, 
González-Sarrías, et al., 2006). This work performed structure analyses, which revealed that 
urolithins A and B exhibited structural characteristics that made these molecules able to bind 
with the α- and β-estrogen receptors. An estrogen receptor (ER) competitive binding assay in 
MCF-7 breast cancer cells showed that both urolithins had affinity for ERα and ERβ receptors, 
although urolithin A bound more effectively than urolithin B, and had higher affinity for the ER
α than for the ERβ receptor. Urolithins showed weaker estrogenic activity than other 
phytoestrogens, such as daidzein, genistein and enterolactone, but they both displayed slightly 
higher anti-estrogenic activity than the previously mentioned phytoestrogens, dose-dependently 
antagonizing the growth-promotion effect of 17-β-estradiol.  In addition, our group also explored 
the hormone-related activity of urolithins A and B using LNCaP androgen-dependent prostate 
adenocarcinoma cells. Considering the reported anti-androgenic activity of other phytoestrogens 
such as isoflavones and the phytoestrogenic effect of urolithins observed by Larrosa and 
colleagues (Larrosa, González-Sarrías, et al., 2006), we hypothesized that urolithins A and B 
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could potentially interact with the androgen receptor. We observed a significant decrease in 
androgen receptor (AR) mRNA and protein levels after treatment with urolithins at several time 
points. Electrophoretic mobility shift assays also revealed that urolithins decreased AR binding 
to androgen response elements, which in turn resulted in a decreased expression of AR regulated 
genes such as klk3 which encodes for prostate-specific antigen (PSA) (Figure 4) (Sánchez-
González et al., 2014). Considering the aforementioned evidence it is possible to conclude that 
urolithins can play a key role in the modulation of hormone and hormone-receptor dependent 
diseases, such as, breast and prostate cancers.   
 
4. HEALTH BENEFITS OF WALNUT POLYPHENOLS AND THEIR DERIVED 
METABOLITES 
Cancer 
Polyphenols exert their anticancer effects by several mechanisms, such as, the reduction 
of pro-oxidative effect of carcinogenic agents (Duthie & Dobson, 1999; Owen et al., 2000), 
modulation of cancer cell signaling and  of cell cycle progression (Corona et al., 2007; Corona et 
al., 2009; Khan & Mukhtar, 2013), promotion of apoptosis (Fabiani et al., 2002; Mantena et al., 
2006), and modulation of enzymatic activities (Adams et al., 2010). Polyphenols have also been 
shown to act on multiple targets in pathways not only related to cellular proliferation and death 
(Fini et al., 2008), but also in inflammation (Kang et al., 2011), angiogenesis (Granci et al., 
2010), and drug and radiation resistance (Garg et al., 2005). In particular, the effect walnut 
polyphenols have on cancer prevention has been studied widely, showing promising results 
(Spaccarotella et al., 2008; Reiter et al., 2013; Hardman, 2014; Sánchez-González et al., 2015).  
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Both in vitro and in vivo studies that assess the role of ellagitannins in several molecular 
pathways related to cancer initiation, development and progression have been performed.  
Prostate 
Prostate cancer is the second most frequently diagnosed cancer and the sixth leading 
cause of cancer death among men worldwide (American Cancer Society, 2011). An important 
target in prostate cancer is the androgen receptor, which is required for the development and 
progression of prostate carcinogenesis.  As previously mentioned, our research group has 
assessed the effect that urolithins have on the modulation of the androgen receptor, which is 
fundamental in prostate cancer progression. We were able to determine an inhibition in both AR 
and PSA gene expression and a decrease in protein levels after incubating androgen-dependent 
LNCaP prostate adenocarcinoma cells with urolithins A and B. In addition, we were able to 
determine that urolithins inhibited the binding of AR to androgen response elements, which are 
transcription factors necessary for the transcription of genes such as PSA.  An induction of 
apoptosis and a decrease in the anti-apoptotic protein BCL-2 were also observed (Sánchez-
González et al., 2014).  In addition, after further study using a functional genomics approach we 
also determined CDKN1A, which encodes for p21 protein, as a node gene of urolithin A activity 
in a prostate cancer cell model. Upon validation, a significant increase in anti-proliferative p21 
mRNA and protein levels was observed. In addition,  increased activity of the apoptotic 
enzymes, caspases 3 and 7 was seen (Sánchez-González et al., 2015). Other authors have also 
observed anti-apoptotic effects in other prostate cancer cells such as PC3 and DU 145, which are 
androgen independent, demonstrating that walnut polyphenols negatively affect prostate cancer 
cell viability via different mechanisms (Vicinanza et al., 2013).   
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Another established target in prostate cancer chemoprevention is a cytochrome P450 
enzyme, CYP1B1. Compounds inhibiting CYP1B1 activity are contemplated to exert beneficial 
effects at three stages of prostate cancer development, that is, initiation, progression, and 
development of drug resistance. Urolithins, especially urolithin A, were found to decrease 
CYP1B1 activity and protein expression in 22Rv1 prostate cancer cells (Kasimsetty et al., 2009).  
Furthermore, both walnut extracts and ellagitannins have also been linked to suppressing prostate 
cancer cell proliferation and inducing apoptosis (Losso et al., 2004; Alshatwi et al., 2012; 
Vicinanza et al., 2013; Naiki-Ito et al., 2015) in several models. These cell-based assays allow 
for the identification of molecular pathways where walnut polyphenols may exert their activity.  
Animal and human studies on the potential link between walnuts and prostate cancer 
prevention are still limited, but the results seem promising. Reiter and colleagues tested whether 
a walnut-enriched diet influenced the growth of prostate cancer xenografts growing in male nude 
mice (Reiter et al., 2013). They found that the walnut-enriched diet reduced the number of 
tumors and the growth of the LNCaP xenografts. These authors hypothesized that the most likely 
explanation for the finding that a walnut-enriched diet forestalled the growth of prostate tumors 
is that the inhibitory effect was a consequence of the combined actions of several 
phytochemicals, among them the polyphenolic compounds. Similarly, another recent in vivo 
study found that prostate tumor weight and growth rate were reduced in the TRAMP (transgenic 
adenocarcinoma of mouse prostate) cancer model after treatment with a walnut diet (Davis et al., 
2012). Like Reiter et al. (2013), the authors stated the beneficial effects of a walnut-enriched diet 
probably represent the effects of multiple constituents in whole walnuts and not due to specific 
bioactive compounds such as, fatty acids or tocopherols.  
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Human studies are still lacking, and a recent study points the fact of a need to better 
design in vitro and in vivo approaches in order to mimic physiological conditions as closely as 
possible (González-Sarrías, Giménez-Bastida, et al., 2010).  This intervention study involving 
sixty-three patients with either benign prostate hyperplasia or prostate cancer divided subjects 
into three groups: controls, walnut intake (35g walnuts/day), or pomegranate intake (200mL 
pomegranate juice/day) for 3 days before prostate surgery. The main metabolite detected after 
consumption was urolithin A glucuronide. No apparent changes in the expression of CDKN1A, 
MKi-67 or c-Myc (all related to cancer cell proliferation) were found after consumption of either 
experimental food treatment. The results from this study demonstrated that conjugates of 
urolithins, specifically glucuronides, and dimethyl ellagic acid can reach and enter the human 
prostate gland upon consumption of ellagitannin-rich sources such as pomegranate juice and 
walnuts. Considering their results and the lack of changes in proliferation markers, these authors 
expressed the need to design better in vitro studies that should focus on the bioactivity and 
exposure time of the actual in vivo metabolites formed upon consumption of ellagitannins.   
(González-Sarrías, Giménez-Bastida, et al., 2010).  Another clinical trial done in healthy men 
showed that consuming walnuts on a regular basis did not influence serum PSA levels although 
it did improve biomarkers of prostate health (Spaccarotella et al., 2008), this indicates a positive 
effect on prostate health of including walnuts as part of men´s diet.  
 As a conclusion, all the previously mentioned findings point out the need for studies 
using whole foods, such as walnuts, in human intervention trials to truly assess their effects on 
prostate cancer and to identify effective, food-based chemoprevention diets for prostate and other 
cancers. 
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Breast Cancer 
Considerable amount of research has focused on the role food bioactive components have 
in the development and progression of breast cancer. In a study conducted by Hardman and 
colleagues (2011), female mice were fed control or walnut-containing diets, and were followed 
for tumor development. Compared to a diet without walnuts, their consumption significantly 
reduced tumor incidence, number of tumors per mouse and their size. Gene expression analyses 
indicated that a walnut diet altered expression of multiple genes associated with proliferation and 
differentiation of mammary epithelial cells. Although specific bioactive components were not 
tested, the results of this study indicate that walnut consumption could contribute to a healthy 
diet for the prevention of breast cancer (Hardman et al., 2011).  
It is well known that an important target in breast cancer research is the estrogen receptor 
since estrogens have a critic role in the development and growth of breast cancer (Clemons and 
Goss, 2001). As such, research addressed to study the interaction of ellagitannins against 
estrogen positive breast cancer models is of interest. In an in vivo study, the role of ellagic acid 
over the expression of miRNAs related to breast cancer was evaluated using an ACI rat model, 
which develops mammary tumors upon estrogen E2 (estradiol) exposure. Recent reports have 
associated several miRNAs with estrogen receptors in breast cancers. Ellagic acid reversed the 
deregulation of a number or miRNAs, such as, miR-375, miR-206, miR-182, miR-122, miR-127 
and miR-183 detected after E2 incubation. It also modulated their target proteins which include 
ERα, cyclin D1, RASD1, FoxO3a, FoxO1, cyclin G1, Bcl-w and Bcl-2. These observations 
provide mechanistic insight into the molecular events behind the chemo-preventive action of 
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ellagic acid specifically in breast cancer (Munagala et al., 2013). Ellagic acid also exhibited the 
potential to down-regulate the 17β-estradiol-induced hTERT α+β+ mRNA expression in MCF-7 
estrogen sensitive breast carcinoma cells (Strati et al., 2009).    
As previously mentioned, the estrogen receptor represents an important target for the 
treatment of hormone-dependent breast cancer with anti-estrogens, due to the effect estrogen has 
on breast cancer cell growth and progression.   The hormone-like activity reported for urolithins 
has been related to their interaction with the estrogen receptor in MCF-7 cells, showing a high 
binding affinity to this hormone receptor (Larrosa, González-Sarrías, et al., 2006), and exerting 
both estrogenic and anti-estrogenic effects. Therefore, urolithins can potentially antagonize the 
response of hormone-dependent breast cancer cells to estrogens.  In addition, the potential anti-
aromatase activity of ellagitannin-derived compounds has been studied in MCF-7aro cells (ER-
positive aromatase overexpressing cells) (Adams et al., 2010). The aromatase enzyme converts 
androgen to estrogen and as such, plays a key role in breast carcinogenesis. They screened a 
panel of ellagitannin-derived compounds and identified six with anti-aromatase activity; 
Urolithin B was shown to most effectively inhibit enzymatic activity. Their results suggested that 
urolithin B likely inhibits the proliferation of MCF7aro breast cancer cells primarily through 
aromatase inhibition, and that anti-proliferative effects caused by the other test compounds may 
be caused by an aromatase-independent mechanism such as direct antagonism of estrogen 
receptor signaling or a combination of aromatase-dependent and independent mechanisms 
(Adams et al., 2010).  Strong anti-proliferative activity was observed after ellagic acid incubation 
in MCF-7  and Hs 578T cell lines (Losso et al., 2004), although it is interesting to note that in 
this study cell lines from different cancer models were studied and the most resistant were the 
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breast cancer cells (Losso et al., 2004). Considering all the previously mentioned studies, the role 
of ellagitannins and derived metabolites in breast cancer prevention is promising. Additional 
studies could aid in further elucidating the molecular effects ellagitannins have in breast cancer 
development and progression inhibition.  
 
Colon Cancer 
Foods rich in ellagitannins could act against colon carcinogenesis as evidenced by several 
studies (Losso et al., 2004; González-Sarrías, Larrosa, et al., 2010; Giménez-Bastida et al., 2012; 
Qiu et al., 2013). Walnut leaves, green husks, and seed extracts showed concentration-dependent 
growth inhibition toward human kidney and colon cancer cells (Carvalho et al., 2010). Exposure 
of Caco-2 (colon adenocarcinoma) cells to ellagic acid and urolithins arrested cell growth at the 
S- and G2/M-phases, which could have been related to a decrease in the expression levels of 
MAPK signaling genes, tumor suppressors and genes involved in cell cycle (González-Sarrías et 
al., 2009). Another signaling pathway known to play a pivotal role in human colon 
carcinogenesis is the Wnt pathway. An inappropriate activation of this signaling cascade is 
observed in 90% of colorectal cancers.  Wnt transcriptional activation was explored in a human 
293T colon cancer cell line, cells were incubated with ellagitannin extracts from several food 
sources, including strawberries and pomegranate, and specific polyphenols, ellagic acid (63μM) 
and urolithin A (39μM). All extracts, ellagic acid, and urolithin A inhibited Wnt-dependent 
signaling, a promising effect against colon carcinogenesis (Sharma et al., 2010).   
A walnut-containing diet has also been shown to inhibit colorectal cancer growth by 
suppressing angiogenesis. In an in vivo study using HT-29 cells (colon carcinoma) injected to 
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mice, tumor growth rate was significantly slower in walnut-fed (27%) compared with corn oil-
fed animals (Nagel et al., 2012). Consequently, final tumor weight was reduced by 33% versus 
control. Walnuts also reduced serum expression levels of angiogenesis factors, including 
vascular endothelial growth factor by 30% and significantly decreased angiogenesis proved by 
CD34 staining.  In addition to the anti-proliferative effects of walnut bioactive compounds, its 
main metabolite, urolithin A has been shown to potentiate the effects of 5-Fluorouracil (5-FU, 
drug of first choice in colorectal cancer therapy) on colon cancer cells. This would suggest the 
need for lower 5-FU doses to achieve therapeutic effects, which could in turn reduce possible 
adverse effects of treatment and may indicate a role of ellagitannins as chemotherapy adjuvants 
(González-Sarrías et al., 2015). Although, further studies are needed to confirm these findings in 
humans and explore underlying mechanisms in more detail, the previously mentioned studies 
highlight several targets modulated by EA and its metabolites in colon cancer.  
Other cancers 
Ellagitannins and their metabolites inhibit cancer cell growth, among other ways, through 
cell cycle arrest and stimulation of apoptosis. The anti-proliferative activities of ellagic acid and 
its metabolites have been evaluated in several human cancer cell lines, some of which have been 
previously mentioned (Adams et al., 2010; Vicinanza et al., 2013; Sánchez-González et al., 
2014, 2015).   Other studies have also evaluated the anti-proliferative activity of ETs and other 
byproducts of their hydrolysis in a diverse range of cancer cell lines.  These include, an in vitro 
study conducted in a human bladder cancer cell line which assessed anti-proliferative activity of 
four ellagitannin metabolites, urolithin A, urolithin B, 8-OMe-urolithin A, and ellagic acid. The 
results from this study suggested that these compounds could inhibit cell proliferation by p38-
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MAPK and/or c-Jun mediated caspase-3 activation and by the reduction of oxidative stress (Qiu 
et al., 2013). Other anti-cancer effects of ellagic acid  have also been observed through  PKC α 
gene down-regulation and decreased activity, resulting in a marked decrease in oxidative stress 
and cell viability in Dalton lymphoma bearing mice (Mishra and Vinayak, 2011), and in a study 
conducted in SH-SY5Y neuroblastoma cells  ellagic acid incubation induced anti-proliferative 
effects including cell detachment, decreased cell viability and induced apoptosis (Fjaeraa and 
Nånberg, 2009). 
 
Cardiovascular Disease 
The characteristic lipid profile of walnuts has been suggested to reduce the risk of 
cardiovascular diseases, exerting its effect by decreasing total and LDL-cholesterol and  
increasing both HDL-cholesterol and the antioxidant defense system (Ros et al., 2004; Nergiz-
Ünal et al., 2013). However, recent studies have shown the potential cardio-protection effects of 
ellagitannins, which could be associated to the modulation of several parameters linked to 
cardiovascular health (Papoutsi et al., 2008; Spaccarotella et al., 2008; Larrosa et al., 2010). One 
of the strongest effects has been observed on oxidative stress and inflammation, in this sense it is 
interesting to explore the potential role of ETs over atherosclerosis.   
The inflammatory process plays an important role in the pathogenesis of atherosclerosis 
through the interaction of the endothelium with immune cells (Kaneto et al., 2010). Numerous 
signaling cascades have been elucidated and, among other functions, the inflammatory cytokine-
induced adhesion molecules in the endothelium play a critical role in the inflammatory process 
and immune response (Han et al., 2007).  Adhesion molecules, namely vascular cell adhesion 
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molecule (VCAM)-1 and intracellular cell adhesion molecule (ICAM)-1, activated by 
inflammatory cytokines such as TNF-α, participate in the initiation of this interaction. Several 
lines of evidence support a crucial role of adhesion molecules in the development of 
atherosclerosis and plaque instability (Blankenberg et al., 2003). Papoutsi et al. (2008) examined 
the effect of a walnut extract and ellagic acid on VCAM-1 and ICAM-1 expression in human 
aortic endothelial cells. Cells were incubated with TNF-α in the absence and presence of walnut 
extract or ellagic acid, both treatments significantly decreased TNF-α-induced endothelial 
expression of VCAM-1 and ICAM-1 (Papoutsi et al., 2008). Authors concluded that walnut 
polyphenols, mainly ellagic acid, show potential as anti-inflammatory substances and provided 
insight into the mechanism of how walnut intake may participate in cardio-protection by 
improving endothelial function.  
Another important intervention of walnut polyphenols as modulators of cardiovascular 
disease, is the protective effect they may have on the susceptibility of LDL to oxidative 
modification and ultimately, on atherosclerosis. In a study conducted by Anderson et al. (2001), 
polyphenol-rich walnut extracts at expected physiologic concentration were studied and 
compared with ellagic acid for their ability to inhibit in vitro plasma and LDL oxidation during 
oxidative stress. LDL oxidation was significantly inhibited by both ellagic acid and the walnut 
extract. These authors concluded that walnut polyphenols are effective inhibitors of in vitro 
plasma and LDL oxidation (Anderson et al., 2001), indicating that in addition to the favorable 
lipid profile of walnuts, their phenolic content must also be considered as a potential contributor 
to the apparent anti-atherogenic effect of walnuts (Casas-Agustench et al., 2011; Estruch et al., 
2013).  
D
ow
nl
oa
de
d 
by
 [U
NI
VE
RS
IT
AT
 D
E 
BA
RC
EL
ON
A]
 at
 10
:14
 18
 Ja
nu
ary
 20
16
 
ACCEPTED MANUSCRIPT 
ACCEPTED MANUSCRIPT 20 
Interestingly, ellagic acid has also been associated with a protective effect on myocardial 
infarction induced damage. Wistar rats were used as a model in order to provide a scientific basis 
for the use of ellagic acid in preventing myocardial infarction (Mari Kannan and Darlin Quine, 
2012). These authors also performed in vitro studies that confirmed the free radical scavenging 
and metal chelating activities of ellagic acid which could be the mechanism responsible for the 
protective action against mitochondrial damage in myocardial infarction. 
The previously mentioned in vitro and in vivo studies provide the basis for elucidating the 
effect of walnut polyphenols over cardiovascular diseases.  Human trials have also been 
performed, granting they do not directly assess the specific effect of polyphenols. Katz et al 
(2012) associated walnuts and their bioactive compounds to impact endothelial function 
favorably (Katz et al., 2012). In a randomized controlled crossover trial, using a population of 
overweight individuals with visceral adiposity, the effects of daily walnut consumption on 
endothelial function and other biomarkers of cardiac risk were investigated. Forty-six overweight 
adults, with elevated waist circumference and 1 or more additional signs of metabolic syndrome, 
were randomly assigned to two 8-week sequences of walnut-enriched ad libitum diet and ad 
libitum diet without walnuts, which were separated by a 4- week washout period. The primary 
outcome measure was the change in flow-mediated vasodilation (FMD) of the brachial artery. In 
this study FMD improved significantly from baseline when subjects consumed a walnut-enriched 
diet as compared with the control diet. There was also a reduction in systolic blood pressure and 
maintenance of the baseline anthropometric values was also observed. Although specific 
components of walnuts were not studied specifically, these authors concluded that the daily 
ingestion of 56g of walnuts improves endothelial function in overweight adults with visceral 
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adiposity (Katz et al., 2012) . This study did not assess polyphenols in particular, but it is a good 
example of the positive cardiovascular health effects of walnuts as a diet component. It would be 
interesting to assess if these effects are caused by the individual bioactive compounds of which 
walnuts are composed of, or if it is a result of the interaction between the various phytochemicals 
they contain.    
 
Neurodegenerative Disease 
Lifestyle factors greatly affect the progression of cognitive decline, with high-risk 
behaviors including unhealthy diet, lack of exercise, smoking, and exposure to environmental 
toxins leading to enhanced oxidative stress and inflammation. Although there is an urgent need 
to develop effective treatments for age-related cognitive decline and neurodegenerative disease, 
prevention strategies are underdeveloped. Thus, potential preventive effects of bioactive 
compounds commonly found in the diet should be explored. As previously mentioned in this 
review, polyphenolic compounds found in walnuts have both anti-inflammatory and anti-oxidant 
properties. Therefore, these compounds might reduce the oxidant and inflammatory load on brain 
cells, but in addition, they improve interneuronal signaling,  increase neurogenesis, and enhance 
sequestration of insoluble toxic protein aggregates (Poulose et al., 2014).   
Amyloid beta-protein (Aβ) is the major component of senile plaques and cerebrovascular 
amyloid deposits in individuals with Alzheimer’s disease. Aβ is known to increase free radical 
production in neuronal cells, leading to oxidative stress and cell death. Selective inhibition of Aβ 
oligomer formation provides an optimum target for Alzheimer’s disease therapy. Several studies 
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have addressed the anti-amyloidogenic activities of walnuts (Lin and Salem, 2007; Muthaiyah et 
al., 2011).  
A walnut extract has been shown to reduce Aβ-mediated cell death, decrease the release 
of lactate dehydrogenase (a marker of membrane damage), and reduce DNA damage as 
evidenced by a decrease in apoptosis and a decrease in ROS generation in a concentration-
dependent manner (Muthaiyah et al., 2011). Although the majority of studies have not explored 
polyphenols specifically, it could be hypothesized that the anti-inflammatory and anti-oxidant 
potential in ellagitannins could be in part responsible for the neuro-protective effect of walnuts. 
It is worth mentioning that ellagic acid could reduce Aβ42-induced neurotoxicity toward SH-
SY5Y neuroblastoma cells (Feng et al., 2009),  thus ellagitannins show a promise in preventing 
Aβ-related neurodegenerative diseases.  
 Another interesting effect of ellagic acid is a potential analgesic property; different 
animal models of pain were used to test possible mechanisms underlying systemic 
antinociception after ellagic acid administration with dose-dependent analgesic effects observed 
(Taghi Mansouri et al., 2013; Mansouri et al., 2015). 
 
3. FUTURE TRENDS AND CONCLUSIONS 
In view of the experimental evidence mentioned in this review, we conclude that walnut 
polyphenols have obvious and numerous disease-preventive properties. The molecular 
functions attributed to walnut polyphenols indicative of their capacity have been performed 
mainly in in vitro studies, which in order to accurately assess biological responses must only use 
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physiologically relevant concentrations. As a consequence, bioavailability and in vivo biological 
efficacy are critical issues that must be correlated before drawing any conclusions on the 
potential health benefits of specific bioactive compounds, including polyphenols.  Nonetheless, 
evidence suggests that incorporating walnuts into a healthy diet could aid in the prevention and 
modulation of several disease states. Although, this review has focused on polyphenols, several 
bioactive compounds in walnuts have been linked to disease prevention, as such, it is important 
to incorporate walnuts as a whole, to be able to reap the benefits of the variety of compounds 
they are composed of. Further research, particularly human trials, are warranted, but current 
evidence is encouraging enough to make walnut polyphenols bioactive compounds that should 
be continued to explore. 
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LEGENDS TO FIGURES  
 
 
Figure 1. Graphic representation of pedunculagin metabolism.  
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Figure 2:  Scheme of the role of ellagitannins on antioxidant related processes in the cell. HO-1: 
heme oxygenase 1, Keap1: kelch-like ECH-associated protein 1, Maf: musculoaponeurotic 
fibrosarcoma oncogene, Nrf2: nuclear factor (erythroid-derived 2)-like 2, SOD: superoxide 
dismutase.  
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Figure 3.  Schematic representation of the effect ellagitannins over the expression of 
inflammation-related molecules. COX-2: cyclooxygenase, GSH: glutathione, IL-10: interleukin 
10, IL-1β: interleukin-1 beta, MDA: malondialdehyde, NF-κB:  nuclear factor-κB , PAI-1: 
plasminogen activator inhibitor 1, PGE2: prostaglandin E2, TNF-α: tumor necrosis factor alpha. 
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Figure 4. Proposed mechanism of the interaction between urolithins A and B with hormone 
receptors in A) LNCaP and B) MCF-7 cells. AR: androgen receptor, ARE: androgen response 
elements, DHT: dihydrotestosterone, ER: estrogen receptor, ERE: estrogen response elements.  
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